Acute renal failure following bone marrow transplantation

Renal Failure

Volumn 20, Issue 3, 1998, Pages 421-435

  Pulla, Bharathi ^a   Barri, Yousri M ^a   Anaissie, Elias ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Acute renal failure; Bone marrow transplantation

Indexed keywords

ALLOPURINOL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BICARBONATE; CREATININE; CYCLOSPORIN; HEMOGLOBIN; HEPARIN; MANNITOL; PLASMINOGEN ACTIVATOR; URIC ACID;

ACUTE KIDNEY FAILURE; BONE MARROW TOXICITY; BONE MARROW TRANSPLANTATION; DIURESIS; HEPATORENAL SYNDROME; HUMAN; HYPOTENSION; LYMPHOPROLIFERATIVE DISEASE; NEPHROTOXICITY; OBSTRUCTIVE UROPATHY; PRIORITY JOURNAL; REVIEW; SEPSIS; VEIN OCCLUSION;

EID: 0031900808     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229809045131     Document Type: Review

References (49)

1. Rieselbach RE, Garnick MD: Renal diseases induced by antineoplastic agents. In: Schrier RW, Gottschalk CW (eds); Diseases of the Kidney. Boston, Little, Brown, 1988, pp 1292-1293.
2. Conger JD: Acute uric acid nephropathy. Med Clin North Am 74:859-871, 1990.
3. Broun ER, Nichols CR, Tricot G, Loehrer PJ, Williams SD: Autologous bone marrow support in the treatment of refractory germ cell tumors. Bone marrow transplant 7:53-56, 1991.
4. Cannell PK, Herrmann RP: Urate metabolism during bone marrow transplantation. Bone Marrow Transplant 10:337-339,1992.
5. Rowle SC: Hematopoietic stem cell cryopreservation: a review of current associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active techniques. J Hematotherapy 1:233-250, 1992.
6. Davis JM, Rowley SC, Braine HG, Plantadosi S, Santos GW: Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 75:781-786, 1990.
7. Kamoto Y, Takaue Y, Saitos, Shimitzu T, Abe T, Sato J, Hirao A, Watanabe T, Kawano Y, Kuroda Y: Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer. Transfusion 33:578-581, 1993.
8. Styler MJ, Topolsky DL, Crilley PA, Covalsesky V, Bryan R, Bulova S, Brodsky I: Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transplant 10:435-438, 1992.
9. Kessinger A, Schmit-Pokomy D, Smith D, Armitage J: Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant 5 (suppl 1): 25-27, 1990.
10. Smith DM, Weisenberger DD, Bierman P, Kessinger A, Vaughan WP, Armitage JO: Acute renal failure associated with autologous bone marrow transplantation. Bone Marrow Transplant 2:195-210,1987.
11. Yellowless P, Greenfield C, McIntyre N: Dimethylsulphoxide induced toxicity. Lancet 2:1004-1006,1980.
12. Zager RA: Heme protein-ischemic interactions at the vascular, intraluminal, and renal tubular cell levels: implications for therapy of myoglobin-induced renal injury. Renal Failure 14:341-344, 1992.
13. Jaenike JR: Micropuncture study of methemoglobin-induced acute renal failure in the rat. J Lab Clin Med 73:459-468, 19.
14. Zager RA, Gamelin LM: Pathogenetic mechanisms in experimental hemoglobinuric acute renal failure. Am J Physiol 25:F446-F455, 1989.
15. Zager RA, O'Quigley J, Zager BK, Alpers CE, Shulman HM, Gamelin LM, Stewart P, Thomas ED: Acute Renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis 13:210-216, 1989.
16. Gruss E, Bemis C, Thomas JF, Garcia-Canton C, Figuera A, Berberana M, Paraiso V, Hernandez-Jaros J, Lopez, Ranada F, Traver JA: Acute renal failure and bone marrow transplantation. Renal Failure 15:671-672, 1993.
17. Baldus WP, Fleitchter RN, Summerskill WHJ: The Kidney in cirrhosis. Clinical and biochemical features of azotemia in hepatic failure. Ann Int Med 60:353-365, 1964.
18. Shuhart MC, McDonald GB: Gastrointestinal and hepatic complications. In: Forman SJ, Blume KG, Thomas ED, Cambridge MA, Blackwell (eds); Bone Marrow Transplantation, 1994, pp 454-481(chapt 33).
19. McDonald GB, Sharma P, Mathews DE, Shulman HM, Thomas ED: Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 4:116-122, 1984.
20. Jones RJ, Lee KS, Beschomer WE, Vogel VG, Grochow LB, Braine HG, Vogelsang GB, Sensenbrenner LL, Santos GW, Saral R: Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 44:778-783, 1983.
21. Ganem G, Saint-Marc Girardin MF, Kuentz M, Cordonnier, Marinello G, Teboul C, Bracconnier F, Vernant JP, Dhumeaux D, Le bourgeois JP: Veno-occlusive disease of the liver after allogenic bone marrow transplantation in man. Int J Radiat Oncol Biol Phys 14:879-884, 1988.
22. Nevill TJ, Barnett MJ, Klingmann HG, Reece DE, Shepherd JD, Phillips GL: Regimen-related toxicity of a busulfan-cyclophosphomide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation. J Clin Oncol 9:1224-1232, 1991.
23. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, Hardin BJ, Shulman HM, Clift RA: Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 118:255-267, 1993.
24. Levy M: Nephrology Forum: Hepatorenal syndrome. Kidney Int 43-737-753, 1993.
25. Sawayi BP, Weinprecht H, Campbell WR, Lorenz JN, Webb RL, Briggs JP, Schnermann J: Direct vasoconstriction as a possible cause of amphotericin B induced nephrotoxicity in rats. J Clin Invest 87:2097-2107, 1991.
26. Butler WT, Benett JE, Alling DW, Westlake PT, Utz JP, Hill GJ: Nephrotoxicity of amphotericin B: Early and late effects in 81 patients. Ann Intern Med 61:175-187, 1964.
27. Moore RD, Smith CR, Lietman PS: Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides. Am J Med 80:1093-1097,1986.
28. Gabrera J, Arroyo U, Ballesto AM, Rimola AJ, Elena M, Gual J, Rodes J: Aminoglycoside nephrotoxicity in cirrhosis. Gastroenterology 82:97-105, 1982.
29. Churchill DN, Hong K, Gault MH: Radiation nephritis following combined abdominal radion and chemotherapy (bleomycin-vinblastine). Cancer 37:1186, 1976.
30. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cortran RS, Gimbrone MA Jr.: Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci 83:4533-4537, 1986.
31. Geriach H, Esposito C, Stern DM: Modulation of endothelial hemostatic properties: An active role in the host response. Ann Rev Med 41:15-24, 1990.
32. Jaattela M: Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachexin. Lab Invest 64:724-742, 1991.
33. Bearman SI, Shuhart MC, Hinds MS, McDonald GB: Recombinant human tissue plasminogen activator for the treatment of established severe veno-occlusive disease of the liver after bone marrow transplantation. Blood 80:2458-2462, 1992.
34. Gale RP, Sparkes RS, Golde DW: Bone marrow margin origin of hepatic macrophages (kuppfer cells) in humans. Science 201:937-938, 1978.
35. Pinsky MR, Matuschak GM: A unifying hypothesis of multiple systems organ failure: failure of host defense homeostasis. J Crit Care 5:108-114, 1990.
36. Zager RA: Nephrology forum: acute renal failure in the setting of bone marrow transplantation. Kidney Int 46:1443-1458, 1994.
37. McDonald GB, Hinds MS, Fisher LD, Schoch HG, et al. Veno-occlusive disease of the liver and multiorgan failure after marrow transplantation: a cohort study of 355 patients. Ann Intern Med 118:255-267, 1993.
38. Tarbel NS, Guinan EC, Neimeyer C, Mauch P, Sallan SE, Weinstein HJ: Late onset of renal dysfunction in survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 15: 99-104,1988.
39. Bergstein J, Andreoli SP, Provisor AJ, Yum M: Radiation nephritis following total body irradiation and cyclophosphamide in preparation of bone marrow transplantation. Transplantation 41:63, 1984.
40. Lawton CA, Barber-Derus SW, Murray KS, Ash RC, Moulder JE: Influence of renal shielding on the incidence of late renal dysfunction associated with T- lymphocyte depleted bone marrow transplantation in adult patients. Int J Radiat Oncol Biol Phys 23:681-686, 1992.
41. Silva VA, Frei-Lahr D, Brown RA, Herzig GP: Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation. J Clin Apheresis 6:16-20, 1991.
42. Yee GC, Self SG, McGuire TR, Carlin J, Sanders JE, Deeg HJ: Serum cyclosporin concentrations and risk of acute graft-versus-host disease after allogeneic marrow transplantation. N Engl J Med 319:65-70,1988.
43. Sullivan KM: Graft-versus-host disease. In: Forman SJ, Blume KG, Thomas ED (eds); Bone Marrow Transplantation. Oxford, Blackwell, 1994, pp 339-362.
44. Deeg HJ, Store R, Thomas ED, Fluornoy N, Kennedy MS, Banaji M, Applebaum FR, Bensinger WL, Buckner CD, Clift RA, Doney K, Fefer A, McGuffin R, Sanders JE, Singer J, Stewart P, Sullivan KM, Witherspoon RP: Cyclosporin as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia. Blood 65:1325-1334, 1985.
45. Kennedy MS, Deeg HJ, Siegel M, Crowley JJ, Storb R, Thomas ED: Acute renal toxicity with combined use of amphotericin B and cyclosporin after marrow transplantation. Transplantation 35:211-215, 1983.
46. Storb R, Deeg HJ, Farewll V, Doney K, et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 68:119-125, 1986.
47. Rosey SR, Russler S, Gottleib M, Ash RC: Low dose amphotericin B prophylaxis against invasive aspergillus infections in allogeneic marrow transplantation. Am J Med 91:484-492, 1991.
48. Goodman JL, Wiston DJ, Greenfield RA, Chandrashekar PH, Fox B, Kaizer H, Shadduck RK, Shea TC, Stiff P, Friedman DJ: A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New Engl J Med 326:845-851, 1992.
49. Cohen EP, Lawton CL, Moulder JE: BMT nephropathy: Radiation nephritis revisited. Nephron 70:217-222, 1995.